Relevance of renal-specific oxidoreductase in tubulogenesis during mammalian nephron development

Yashpal S. Kanwar, Qiwei Yang, Yufeng Tian, Sun Lin, Jun Wada, Sumant Chugh, Satish Srivastava

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Renal-specific oxidoreductase (RSOR), an enzyme relevant to diabetic nephropathy, is exclusively expressed in renal tubules. Studies were initiated to determine whether, like other tubule-specific proteins, it selectively modulates tubulogenesis. Northern blot analyses revealed a ∼1.5-kb transcript, and RSOR expression was detectable in mice embryonic kidneys at day 13, gradually increased by day 17, and extended into neo- and postnatal periods. RSOR mRNA and protein expression was confined to proximal tubules, commencing at gestational day 17 and increasing subsequently, but remained absent in glomeruli and medulla. Treatment with RSOR antisense oligodeoxynucleotide resulted in a dose-dependent dysmorphogenesis of metanephric explants harvested at gestational day 13. The explants were smaller and had expanded mesenchyme, and the population of tubules was markedly decreased. The glomeruli were unaffected, as assessed by mRNA expression of glomerular epithelial protein 1 and reactivity with wheat germ agglutinin. Antisense treatment led to a selective reduction of RSOR mRNA. Immunoprecipitation also indicated a selective translational blockade of RSOR. These findings suggest that RSOR is developmentally regulated, exhibits a distinct spatiotemporal distribution, and probably plays a role in tubulogenesis.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Renal Physiology
Volume282
Issue number4 51-4
StatePublished - 2002

Fingerprint

Nephrons
Oxidoreductases
Kidney
Messenger RNA
Class 3 Receptor-Like Protein Tyrosine Phosphatases
Wheat Germ Agglutinins
Oligodeoxyribonucleotides
Diabetic Nephropathies
Mesoderm
Immunoprecipitation
Northern Blotting
Proteins
Enzymes

Keywords

  • Diabetes mellitus
  • Nephrogenesis

ASJC Scopus subject areas

  • Physiology

Cite this

Kanwar, Y. S., Yang, Q., Tian, Y., Lin, S., Wada, J., Chugh, S., & Srivastava, S. (2002). Relevance of renal-specific oxidoreductase in tubulogenesis during mammalian nephron development. American Journal of Physiology - Renal Physiology, 282(4 51-4).

Relevance of renal-specific oxidoreductase in tubulogenesis during mammalian nephron development. / Kanwar, Yashpal S.; Yang, Qiwei; Tian, Yufeng; Lin, Sun; Wada, Jun; Chugh, Sumant; Srivastava, Satish.

In: American Journal of Physiology - Renal Physiology, Vol. 282, No. 4 51-4, 2002.

Research output: Contribution to journalArticle

Kanwar, YS, Yang, Q, Tian, Y, Lin, S, Wada, J, Chugh, S & Srivastava, S 2002, 'Relevance of renal-specific oxidoreductase in tubulogenesis during mammalian nephron development', American Journal of Physiology - Renal Physiology, vol. 282, no. 4 51-4.
Kanwar, Yashpal S. ; Yang, Qiwei ; Tian, Yufeng ; Lin, Sun ; Wada, Jun ; Chugh, Sumant ; Srivastava, Satish. / Relevance of renal-specific oxidoreductase in tubulogenesis during mammalian nephron development. In: American Journal of Physiology - Renal Physiology. 2002 ; Vol. 282, No. 4 51-4.
@article{12bf0a9f7a71475e8b1133310c410597,
title = "Relevance of renal-specific oxidoreductase in tubulogenesis during mammalian nephron development",
abstract = "Renal-specific oxidoreductase (RSOR), an enzyme relevant to diabetic nephropathy, is exclusively expressed in renal tubules. Studies were initiated to determine whether, like other tubule-specific proteins, it selectively modulates tubulogenesis. Northern blot analyses revealed a ∼1.5-kb transcript, and RSOR expression was detectable in mice embryonic kidneys at day 13, gradually increased by day 17, and extended into neo- and postnatal periods. RSOR mRNA and protein expression was confined to proximal tubules, commencing at gestational day 17 and increasing subsequently, but remained absent in glomeruli and medulla. Treatment with RSOR antisense oligodeoxynucleotide resulted in a dose-dependent dysmorphogenesis of metanephric explants harvested at gestational day 13. The explants were smaller and had expanded mesenchyme, and the population of tubules was markedly decreased. The glomeruli were unaffected, as assessed by mRNA expression of glomerular epithelial protein 1 and reactivity with wheat germ agglutinin. Antisense treatment led to a selective reduction of RSOR mRNA. Immunoprecipitation also indicated a selective translational blockade of RSOR. These findings suggest that RSOR is developmentally regulated, exhibits a distinct spatiotemporal distribution, and probably plays a role in tubulogenesis.",
keywords = "Diabetes mellitus, Nephrogenesis",
author = "Kanwar, {Yashpal S.} and Qiwei Yang and Yufeng Tian and Sun Lin and Jun Wada and Sumant Chugh and Satish Srivastava",
year = "2002",
language = "English (US)",
volume = "282",
journal = "American Journal of Physiology - Endocrinology and Metabolism",
issn = "0193-1849",
publisher = "American Physiological Society",
number = "4 51-4",

}

TY - JOUR

T1 - Relevance of renal-specific oxidoreductase in tubulogenesis during mammalian nephron development

AU - Kanwar, Yashpal S.

AU - Yang, Qiwei

AU - Tian, Yufeng

AU - Lin, Sun

AU - Wada, Jun

AU - Chugh, Sumant

AU - Srivastava, Satish

PY - 2002

Y1 - 2002

N2 - Renal-specific oxidoreductase (RSOR), an enzyme relevant to diabetic nephropathy, is exclusively expressed in renal tubules. Studies were initiated to determine whether, like other tubule-specific proteins, it selectively modulates tubulogenesis. Northern blot analyses revealed a ∼1.5-kb transcript, and RSOR expression was detectable in mice embryonic kidneys at day 13, gradually increased by day 17, and extended into neo- and postnatal periods. RSOR mRNA and protein expression was confined to proximal tubules, commencing at gestational day 17 and increasing subsequently, but remained absent in glomeruli and medulla. Treatment with RSOR antisense oligodeoxynucleotide resulted in a dose-dependent dysmorphogenesis of metanephric explants harvested at gestational day 13. The explants were smaller and had expanded mesenchyme, and the population of tubules was markedly decreased. The glomeruli were unaffected, as assessed by mRNA expression of glomerular epithelial protein 1 and reactivity with wheat germ agglutinin. Antisense treatment led to a selective reduction of RSOR mRNA. Immunoprecipitation also indicated a selective translational blockade of RSOR. These findings suggest that RSOR is developmentally regulated, exhibits a distinct spatiotemporal distribution, and probably plays a role in tubulogenesis.

AB - Renal-specific oxidoreductase (RSOR), an enzyme relevant to diabetic nephropathy, is exclusively expressed in renal tubules. Studies were initiated to determine whether, like other tubule-specific proteins, it selectively modulates tubulogenesis. Northern blot analyses revealed a ∼1.5-kb transcript, and RSOR expression was detectable in mice embryonic kidneys at day 13, gradually increased by day 17, and extended into neo- and postnatal periods. RSOR mRNA and protein expression was confined to proximal tubules, commencing at gestational day 17 and increasing subsequently, but remained absent in glomeruli and medulla. Treatment with RSOR antisense oligodeoxynucleotide resulted in a dose-dependent dysmorphogenesis of metanephric explants harvested at gestational day 13. The explants were smaller and had expanded mesenchyme, and the population of tubules was markedly decreased. The glomeruli were unaffected, as assessed by mRNA expression of glomerular epithelial protein 1 and reactivity with wheat germ agglutinin. Antisense treatment led to a selective reduction of RSOR mRNA. Immunoprecipitation also indicated a selective translational blockade of RSOR. These findings suggest that RSOR is developmentally regulated, exhibits a distinct spatiotemporal distribution, and probably plays a role in tubulogenesis.

KW - Diabetes mellitus

KW - Nephrogenesis

UR - http://www.scopus.com/inward/record.url?scp=0036087138&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036087138&partnerID=8YFLogxK

M3 - Article

VL - 282

JO - American Journal of Physiology - Endocrinology and Metabolism

JF - American Journal of Physiology - Endocrinology and Metabolism

SN - 0193-1849

IS - 4 51-4

ER -